Is there a generic for Cinoxacin?

Yes. The FDA Orange Book lists 2 approved generic (ANDA) applications for Cinoxacin, referencing the brand CINOBAC. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Cinoxacin?

CINOBAC (NDA 018067, LILLY) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Cinoxacin are approved?

Cinoxacin is approved in the following dosage form: capsule.

FDA Orange Book · active-ingredient family

Cinoxacin

Cinoxacin is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CINOBAC · NDA 018067

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · capsule

Product	Applicant	Application	TE	Approved
CINOBAC×2	LILLY	NDA 018067	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (2)

Product	Applicant	Application	TE	Approved
CINOXACIN	TEVA	ANDA 073005	—	Feb 28, 1992
CINOXACIN	TEVA	ANDA 073006	—	Feb 28, 1992

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cinoxacin — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo